ATERIAN INC (ATER)

US02156U2006 - Common Stock

2.18  -0.01 (-0.46%)

Fundamental Rating

2

Overall ATER gets a fundamental rating of 2 out of 10. We evaluated ATER against 66 industry peers in the Household Durables industry. ATER has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ATER is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year ATER has reported negative net income.
In the past year ATER has reported a negative cash flow from operations.
In the past 5 years ATER always reported negative net income.
ATER had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

ATER has a worse Return On Assets (-35.04%) than 95.31% of its industry peers.
The Return On Equity of ATER (-59.66%) is worse than 89.06% of its industry peers.
Industry RankSector Rank
ROA -35.04%
ROE -59.66%
ROIC N/A
ROA(3y)-107.09%
ROA(5y)-88.07%
ROE(3y)-168.25%
ROE(5y)-264.55%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 58.40%, ATER belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
In the last couple of years the Gross Margin of ATER has grown nicely.
ATER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.61%
GM growth 5Y6.81%

2

2. Health

2.1 Basic Checks

ATER does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATER has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ATER has been increased compared to 5 years ago.
ATER has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -17.18, we must say that ATER is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -17.18, ATER is not doing good in the industry: 98.44% of the companies in the same industry are doing better.
ATER has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.24, ATER is in line with its industry, outperforming 57.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -17.18
ROIC/WACCN/A
WACC10.07%

2.3 Liquidity

ATER has a Current Ratio of 1.92. This is a normal value and indicates that ATER is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.92, ATER is doing worse than 62.50% of the companies in the same industry.
ATER has a Quick Ratio of 1.14. This is a normal value and indicates that ATER is financially healthy and should not expect problems in meeting its short term obligations.
ATER's Quick ratio of 1.14 is fine compared to the rest of the industry. ATER outperforms 64.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.14

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.27% over the past year.
Looking at the last year, ATER shows a very negative growth in Revenue. The Revenue has decreased by -34.92% in the last year.
ATER shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.24% yearly.
EPS 1Y (TTM)75.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.96%
Revenue 1Y (TTM)-34.92%
Revenue growth 3Y-8.43%
Revenue growth 5Y14.24%
Sales Q2Q%-33.85%

3.2 Future

ATER is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.84% yearly.
ATER is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.88% yearly.
EPS Next Y76.82%
EPS Next 2Y33.55%
EPS Next 3Y22.11%
EPS Next 5Y14.84%
Revenue Next Year-30%
Revenue Next 2Y-14.08%
Revenue Next 3Y-8.18%
Revenue Next 5Y15.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATER. In the last year negative earnings were reported.
Also next year ATER is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ATER's earnings are expected to grow with 22.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.55%
EPS Next 3Y22.11%

0

5. Dividend

5.1 Amount

ATER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATERIAN INC

NASDAQ:ATER (12/18/2024, 4:13:00 PM)

2.18

-0.01 (-0.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.10M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.04%
ROE -59.66%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 58.4%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.92
Quick Ratio 1.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)75.27%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y76.82%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-34.92%
Revenue growth 3Y-8.43%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y